In ITP, a significant proportion of the autoantibodies target platelet glycoprotein (GP) receptors that are responsible for platelet activation, such as GPIIb/IIIa and GPIb/IX/V complexes. The gene discussed is ITGA2B; the disease is autoimmune thrombocytopenic purpura.